Rhythm Pharmaceuticals Inc (RYTM)
41.06
+0.93
(+2.32%)
USD |
NASDAQ |
Jun 28, 16:00
41.06
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Accounts Receivable (Quarterly): 14.70M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.70M |
| December 31, 2023 | 14.87M |
| September 30, 2023 | 14.54M |
| June 30, 2023 | 13.83M |
| March 31, 2023 | 8.117M |
| December 31, 2022 | 6.224M |
| September 30, 2022 | 3.328M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.707M |
| March 31, 2022 | 0.862M |
| December 31, 2021 | 1.025M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
14.87M
Maximum
Dec 2023
7.200M
Average
6.224M
Median
Dec 2022
Accounts Receivable (Quarterly) Benchmarks
| Pfizer Inc | 10.99B |
| Amgen Inc | 6.776B |
| Amicus Therapeutics Inc | 76.43M |
| Viking Therapeutics Inc | -- |
| Arvinas Inc | -- |